drugset / Trial / NCT01210014

Systemic Zinc Sulphate in Treatment of Recurrent Aphthous Ulcerations:A Doubleblind, Placebo Controled Study

NCT01210014

Phase 2 Completed 14 enrolled Qazvin University Of Medical Sciences
RandomizedParallel-groupDouble-blindTreatment

Summary

Recurrent aphthous stomatitis (RAS) is one of the most common of oral mucosa diseases that affects approximately 20% of the general population. Despite the fact that clinical, pathologic and therapeutic feature of the disease has been comprehensively studied, the pathophysiology of aphthous ulcers remains incompletely understood. Zinc is a potent catalyst of wound healing and zinc deficiency may be a common cause of delayed tissue repair. Use of zinc sulfate in promotion wound healing and preservation of epithelial integrity advocated its possible use in the treatment or prevention of recurrent oral ulcers. The purpose of the present study was to determine of systemic zinc sulphate in the treatment of recurrent aphthous stomatitis.

Timeline

Start
2008-04
Primary completion
2009-04
Completion
2009-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zinc Sulfate Unknown 220 mg

Indications